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Abstract
Aims/hypothesis Impaired intestinal barrier function is
observed in type 1 diabetes patients and animal models of
the disease. Exposure to diabetogenic antigens from the
intestinal milieu due to a compromised intestinal barrier is
considered essential for induction of the autoimmune
process leading to type 1 diabetes. Since a hydrolysed
casein (HC) diet prevents autoimmune diabetes onset in
diabetes-prone (DP)-BioBreeding (BB) rats, we studied the
role of the HC diet on intestinal barrier function and,
therefore, prevention of autoimmune diabetes onset in this
animal model.
Methods DP-BB rats were fed the HC diet from weaning
onwards and monitored for autoimmune diabetes develop-
ment. Intestinal permeability was assessed in vivo by
lactulose–mannitol test and ex vivo by measuring trans-
epithelial electrical resistance (TEER). Levels of serum
zonulin, a physiological tight junction modulator, were
measured by ELISA. Ileal mRNA expression of Myo9b,
Cldn1, Cldn2 and Ocln (which encode the tight junction-
related proteins myosin IXb, claudin-1, claudin-2 and
occludin) and Il-10, Tgf-ß (also known as Il10 and Tgfb,
respectively, which encode regulatory cytokines) was
analysed by quantitative PCR.
Results The HC diet reduced autoimmune diabetes by 50%
in DP-BB rats. In DP-BB rats, prediabetic gut permeability
negatively correlated with the moment of autoimmune
diabetes onset. The improved intestinal barrier function
that was induced by HC diet in DP-BB rats was visualised
by decreasing lactulose:mannitol ratio, decreasing serum
zonulin levels and increasing ileal TEER. The HC diet
modified ileal mRNA expression of Myo9b, and Cldn1 and
Cldn2, but left Ocln expression unaltered.
Conclusions/interpretation Improved intestinal barrier func-
tion might be an important intermediate in the prevention of
autoimmune diabetes by the HC diet in DP-BB rats. Effects
on tight junctions, ileal cytokines and zonulin production
might be important mechanisms for this effect.
Electronic supplementary material The online version of this article
(doi:10.1007/s00125-010-1903-9) contains supplementary material,
which is available to authorised users.
J. T. J. Visser (*):A. Hoogendijk: M. W. Boer:
S. Beijer-Liefers:A. Zandvoort: J. Rozing
Department of Cell Biology, Section Immunology,
University Medical Center Groningen, University of Groningen,
PO Box 196, 9700 AD Groningen, the Netherlands
e-mail: j.t.j.visser@med.umcg.nl
K. Lammers: A. Fasano
Mucosal Biology Research Center, University of Maryland,
Baltimore, MD, USA
H. Harmsen:G. Welling
Department of Medical Microbiology,
University Medical Center Groningen, University of Groningen,
Groningen, the Netherlands
S. Brugman
University Medical Center Utrecht, Department of Pediatrics,
Wilhelmina Children’s Hospital,
Utrecht, the Netherlands
F. Stellaard
Department of Laboratory Medicine, Laboratory of Liver,
Digestive and Metabolic Diseases,
University Medical Center Groningen, University of Groningen,
Groningen, the Netherlands
N. A. Bos
University Medical Center Groningen, University of Groningen,
Institute of Medical Education,
Groningen, the Netherlands
Diabetologia (2010) 53:2621–2628
DOI 10.1007/s00125-010-1903-9Keywords BB rat.Cytokines.Hydrolysed casein diet.
Intestinal barrier.Tight junctions.Type 1 diabetes
Abbreviations
BB BioBreeding
DP Diabetes-prone
DR Diabetes-resistant
HC Hydrolysed casein
LA/MA Lactulose–mannitol (test)
TEER Transepithelial electrical resistance
Introduction
Both genetic and environmental factors are pivotal for the
induction of type 1 diabetes. Possible environmental
diabetogenic factors are dietary products and bacterial/viral
infections [1, 2]. These diabetogenic triggers can induce an
immune cascade, eventually leading to the autoimmune
process that is typical of type 1 diabetes [1, 2].
We and others have shown that diet and gut microbiota
are critical for autoimmune diabetes pathogenesis in the
diabetes-prone (DP) BioBreeding (BB) rat model of type 1
diabetes [1, 3–8]. When fed a hydrolysed casein (HC) diet,
only ±50% of DP-BB rats develop autoimmune diabetes [1,
3–6]. These studies also showed that besides lack of
diabetogenic antigens in the food, skewing the (mucosal)
immune response towards a less pathogenic Th2 phenotype
and the induction of islet neogenesis are important
mechanisms in the prevention of type 1 diabetes by the
HC diet [1, 3–6].
There is growing evidence that a third factor, increased
intestinal permeability, underlies the pathogenesis and/or
perpetuation of at least some autoimmune disorders such as
Crohn’s disease and coeliac disease [9, 10]. Intriguingly,
type 1 diabetes patients and animal models of type 1
diabetes show an impaired intestinal barrier function and
signs of intestinal inflammation that precede the onset of
type 1 diabetes [11–21]. In type 1 diabetes patients and
DP-BB rats increased serum zonulin levels were found [13,
14]. Zonulin, the human analogue of Zot from Vibrio
cholerae, is an intestinal physiological modulator of tight
junctions. By binding to its receptor, this protein activates
signalling pathways that cause opening of the tight
junctions and therewith increased intestinal permeability
[12]. Blocking the zonulin receptor by a specific antagonist
led to reduced intestinal permeability in vitro and in vivo
[14, 22, 23], and prevented the increase of intestinal
permeability caused by bacterial agents or gliadin [23,
24]. Interestingly, zonulin antagonists restored the intestinal
barrier function and subsequently delayed or prevented the
development of autoimmune diabetes in DP-BB rats [14].
Food components and gut-derived bacteria can affect
intestinal barrier integrity [12, 23, 24], but the role of the
intestinal barrier in preventing autoimmune diabetes by HC
diet has not been thoroughly investigated. It was shown that
a HC diet improves the intestinal integrity of DP-BB rats
[7, 16], but these studies did not investigate the effect of the
HC diet on tight junctions, the zonulin system, gut micro-
biota and the relation with type 1 diabetes development.
We therefore investigated whether, besides the above-
mentioned mechanisms, restoration of the impaired intesti-
nal barrier function (with emphasis on tight junction
proteins) also contributes to the prevention of autoimmune
diabetes by a HC diet in DP-BB rats.
Methods
Animals Rats were derived from the Worcester DP-BB and
diabetes-resistant (DR) BB strain, but were maintained and
bred at our institutional Central Animal Facility under
specific-pathogen-free and viral-antibody-free conditions
[25]. The animals received humane care in compliance with
the principles of laboratory animal care (NIH publication no.
85-23; revised 1985) and the Dutch law on experimental
animal care. The university Ethical Board for Animal
Studies approved all animal experiments reported in this
study.
Dietary intervention protocol Two dietary intervention
experiments were performed.
In the first, experiment 1, DP-BB rats were given the HC
diet (n=18) or a standard diet (n=16) from weaning
onwards and monitored for the development of auto-
immune diabetes. At 65 days of age, just before DP-BB rats
start to develop autoimmune diabetes, a lactulose–mannitol
(LA/MA) assay as described by Meddings et al. [16] was
performed to establish intestinal permeability in the small
intestine. After subjection to the LA/MA test, the rats were
monitored until 140 days of age. Animals were weighed
three times per week. In case of weight loss or suspicion of
diabetes, blood glucose was measured in tail vein blood
using a glucose sensor (Reflolux S; Boehringer, Mannheim,
Germany). When blood glucose exceeded 15 mmol/l (non-
fasting), rats were considered diabetic and killed.
In the second intervention, experiment 2, another group
of DP-BB rats was fed the HC diet (n=37) or the standard
diet (n=33) from weaning onwards. At fixed time points
(25, 35, 45, 55 and 65 days of age) rats were killed. Ileum
tissue was collected to investigate the effect of the HC diet
over time on the intestinal barrier function by measuring
mRNA expression of tight junction proteins and the ileal
transepithelial electrical resistance (TEER). The TEER was
measured on ileal tissue obtained at 65 days of age. In
2622 Diabetologia (2010) 53:2621–2628addition, ileal mRNA expression of the cytokines Ifn-γ
(also known as Ifng), Tnf-α (also known as Tnf), Il-10 (also
known as Il10) and Tgf-ß (also known as Tgfb1) was
measured. DR-BB rats of 21 to 50 days of age (n= 5 )o r5 1
to 70 days of age (n=25) were used as control rats.
Diet The standard plant-based diet used was a standard
laboratory rodent diet (RMH-B diet; Arie Blok, Woerden, the
Netherlands). The HC diet (TD99482; Harlan-Teklad Custom
Research, Madison, WI, USA) is a modification of the
AIN-93G diet and contained 200 g/kg HC (as source
of amino acids), 3 g/kg L-cysteine, 509.8 g/kg corn starch,
120 g/kg sucrose, 70 g/kg soy-bean oil, 50 g/kg cellulose,
35 g/kg mineral mix, 10 g/kg vitamin mix, 2 g/kg choline
bitartrate and 0.20 g/kg butylated hydroxyanisole antioxidant.
LA/MA test for measuring intestinal permeability in vivo
The LA/MA test is a non-invasive technique to measure
intestinal permeability in vivo. The sugar alcohol mannitol,
which is a small molecule, permeates the intestinal mucosa
via a transcellular pathway through the water-filled pores of
the cell membrane, whereas the larger disaccharide molecule
lactulose uses a paracellular route through the junctional
complexes between adjacent enterocytes. An increased
uptake of lactulose (associated with a high lactulose:
mannitol ratio) indicates a damaged barrier. Therefore, a
reduction of the intestinal permeability will lead to a lower
lactulose uptake and a decreased lactulose:mannitol ratio in
the urine. This test allowed us to investigate whether the rats
with high intestinal permeability in the prediabetic phase
would indeed develop autoimmune diabetes.
A LA/MA assay as described by Meddings et al. [16]
was performed to establish intestinal permeability in the
small intestine.Briefly,astock solution wasmade containing
4 g mannitol and 6 g lactulose per 100 ml distilled water.
Enough solution was made to give each rat 2 ml of the probe.
Rats were placed in stainless steel metabolism cages with
wire bottoms to separate faeces from urine. Rats were denied
access to water for 3 h, at which point they were allowed free
access to water for the remainder of the experiment. Urine
was collected for a total of 24 h, after which rats were
returned to their normal cages. Urine volumes were
measured and the urine composition was analysed by HPLC
as described previously [16].
Final data were reported as a ratio of fractional excretions
(lactulose:mannitol). Fractional excretion is defined as the
fraction of the gavaged dose recovered in the urine sample.
Snapwell assay for measuring TEER An indicator of
intestinal permeability, TEER was measured on ileum samples
in vitro by snapwell assay as described by Watts et al. [14],
with some minor modifications. A small sample (length
~50 mm) was taken from the ileum. During the time between
killing of the animal and mounting in the snapwells (Corning,
Schiphol-rijk, the Netherlands), the samples were kept in
DMEM (with 4.5 g/l glucose) (Gibco, Breda, the Netherlands)
at 4°C. Before mounting, the intestinal pieces were cleaned of
faeces by gently pulling the intestine over a 1 ml pipette and
then cut open longitudinally. The intestine was cleaned further
bygentlymovingit,withthemucosallayerfacingdownwards,
in a Petri-dish with approximately 1 ml medium. A piece was
cut out, placed on a filter with the mucosal layer facing
upwards, sandwiched between two disks and put in the
snapwell insert. This insert was placed in a pre-warmed six-
well plate containing 2 ml DMEM in each well. On top of the
insert 450 μl DMEM was added. The tissue was mounted
within 15 min after excision and the plates were incubated at
37°C. The TEER measurements were done using a Millipore
Millicell-ERS meter (Millipore, Amsterdam, the Netherlands)
at30,60,90,120and180minafterexcision.TheTEERshown
in this paper was measured at 60 min after tissue excision.
Quantitative PCR of tight junction proteins and cytokines
RNA was isolated from ileal tissue and expression of
Myo9b, Cldn1, Cldn2 and Ocln mRNA (encoding the tight-
junction-related proteins myosin IXb, claudin-1, claudin-2
and occludin) and Ifn-γ, Il-10, Tgf-ß and Tnf-α mRNA
(encoding cytokines) was analysed. To isolate RNA from
the intestine, frozen tissue (±1 cm, stored at −80°C) was
homogenised in 1 ml of TRI reagent (Sigma-Aldrich,
Zwijndrecht, the Netherlands) and mRNA was isolated
using the TRI reagent mRNA isolation method. The
concentration of the isolated mRNA was determined using
a nanodrop (ND-1000; Isogen, Maarsen, the Netherlands).
Measurement was done at the 230 nm absorption spectrum
for RNA. Isolated mRNA (5 μg) was converted to cDNA
using a kit (SuperScript II Reverse Transcriptase kit;
Invitrogen Life Technologies, Breda, the Netherlands). To
measure differences in expression of genes for tight
junction-related proteins, transcript levels of Myo9b, Cldn1,
Cldn2, Ocln and the housekeeping gene hypoxanthine
phosphoribosyl-transferase (Hprt) were quantified using
real-time PCR (for primer sequences see Electronic supple-
mentary material [ESM] Table 1). Real-time PCR analysis
was performed using iQ SYBR Green Supermix (Bio-Rad
Laboratories, Veenendaal, the Netherlands) according to the
manufacturer’s instructions; detection was by iCycler iQ Real-
Time PCR Detection System (Bio-Rad), using the following
programme:3min95°C,40cyclesof30sat 95°Candof30s
at 60°C, and of 10 s at 58°C, then 80 times an increase in
temperature of 0.5°C to create a melting curve. Results were
expressed as ratio of target gene, Hprt, according to a
mathematical method described by Pfaffl et al. [26].
Zonulin ELISA Serum zonulin levels were analysed by the
UMCenterforCeliacResearchattheUniversityofMaryland
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Sapone et al. [15].
Statistical analysis Difference in survival was calculated by
thelogranktestforKaplan–Meiersurvivalcurves.Differences
in zonulin levels and lactulose:mannitol ratio were calculated
using the Mann–Whitney U test. Differences in TEER and
expression of tight junction proteins and cytokine levels were
calculated by Kruskal–Wallis test followed by the Mann–
Whitney U test to identify the difference between the groups.
Correlations were tested for significance using the Spearman
correlation method. A p value of <0.05 was considered
significant.
Results
Relation between the level of prediabetic gut permeability
and autoimmune diabetes development, and effects of the HC
diet on intestinal barrier function in DP-BB rats As
previously reported by our group and others [1, 3–7], the
HC diet prevented and delayed the onset of autoimmune
diabetes in DP-BB rats (Fig. 1a).
As seen in Fig. 1b, our results show that HC diet fed rats
had a reduced urinary lactulose:mannitol ratio (i.e. less
leaky gut). This shows that feeding the rats the HC diet
improves intestinal integrity. Interestingly, in both groups,
there was a significant correlation between the day of
autoimmune diabetes onset and the prediabetic urinary
lactulose:mannitol ratio at 65 days of age (Fig. 1c, d). In the
rats on a standard diet this correlation was present when all
the rats are included (diabetic and non-diabetic rats)
(Fig. 1c) and when only the diabetic rats were analysed
(Fig. 1d). In rats fed a HC diet, the correlation was only
sizable when the diabetic rats were analysed. These results
indicate a relation between prediabetic intestinal barrier
function and the moment of diabetes outcome.
The HC diet increases ileal TEER in DP-BB rats The ileal
TEER of DP-BB rats fed the HC diet was measured ex vivo
at 65 days of age using the microsnapwell assay described
previously [14]. As control groups, DR-BB rats and DP-BB
rats fed the standard diet were used. DP-BB rats on the
standard diet had a lower TEER (i.e. increased intestinal
permeability) than DR-BB rats on the same diet (Fig. 2),
confirming previous observations [13]. DP-BB rats that were
fed the HC diet showed an increased TEER as compared
with DP-BB rats on the standard diet (Fig. 2), confirming
and extending the LA/MA data as shown in Fig. 1.
Impaired ileal mRNA expression of tight junction proteins
in DP-BB rats is restored by a HC diet Tight junctions in
gut epithelia are pivotal for maintenance of intestinal barrier
function [27–29]. Therefore, we investigated the effect of
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Fig. 1 HC diet, intestinal permeability and autoimmune diabetes
development in DP-BB rats. a Kaplan–Meier survival curve showing
the development of autoimmune diabetes in DP-BB rats fed a HC diet
(white circles) or a standard diet (black circles). p<0.05, logrank test
for Kaplan–Meier survival curves. b Urinary lactulose:mannitol ratio
established at 65 days of age in DP-BB rats on the indicated diet.
Standard diet, n=12 (three urinary samples not analysed owing to
sampling problems; one rat excluded because it developed diabetes
during LA/MA test); HC diet, n=18. *p<0.05 c, d Correlation
between lactulose:mannitol ratio at 65 days of age and the age of
diabetes onset in DP-BB rats fed the HC diet (white circles, dotted
lines) or the standard diet (black circles, continuous lines). The data
in c were analysed including the rats who did not develop type 1
diabetes before 140 days of age (marked by the oval). Dotted line:
HC diet-fed DP-BB rats, r=−0.4463, p = NS; continuous line:
standard diet-fed DP-BB rats, r=−0.6819, p=0.0146. Data in d were
analysed excluding the rats who did not develop type 1 diabetes
before 140 days of age. Dotted line: HC diet-fed DP-BB rats,
r=−0.7122, p=0.0209; continuous line: standard diet-fed DP-BB
rats, r=−0.6041, p=0.0490
1,500 **
1,000
T
E
E
R
500
DR-BB DP-BB DP-BB
Standard
diet
Standard
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Fig. 2 DP-BB rats have reduced ileal TEER as compared with DR-
BB rats or DP-BB rats fed the HC diet. Rats were killed at 65 days of
age and their ileal TEER measured as described. DR-BB rats fed
standard rodent diet, n=17; DP-BB rats on the standard diet, n=10;
DP-BB rats on the HC diet, n=21. The data are presented as a scatter
dot plot with the mean indicated by a horizontal line. *p<0.05
2624 Diabetologia (2010) 53:2621–2628the HC diet on mRNA expression of Myo9b, Cldn1, Cldn2
and Ocln, which encode proteins necessary for tight
junction functionality.
No differences were observed regarding ileal Ocln mRNA
expression(Fig.3a). Myob expression in the ileum of DP-BB
rats was increased as compared with that in DR-BB rats
(Fig. 3b). Strikingly, feeding the HC diet to DP-BB rats led
to a significant decrease in Myo9b expression in the ileum of
DP-BB rats. Interestingly, the longer the DP-BB rats were
fed the HC diet, the lower the expression of Myo9b was.
As shown in Fig. 3c, Cldn1 expression in the ileum of
DP-BB rats declined over time and at >50 days of age was
lower than in DR-BB rats. Feeding the HC diet to DP-BB
rats resulted in an increase of Cldn1 expression in the ileum
of the DP-BB rats. Above 50 days of age, Cldn2 expression
in the ileum of DP-BB rats was increased as compared with
that in DR-BB rats (Fig. 3d). Feeding DP-BB rats the HC
diet reduced the expression of Cldn2 to levels observed in
DR-BB rats on the standard diet (Fig. 3d).
IncreasedilealmRNAexpressionofTgf-ßandIl-10inDP-BB
rats fed a HC diet The expression of Tgf-ß and Il-10 in the
ileum of HC-fed DP-BB rats was increased as compared
with that in DP-BB rats on the standard diet (Fig. 4).
Expression in the ileum of HC-fed rats was comparable to
expression levels found in the DR-BB rats. No differences
were observed regarding the expression of Ifn-γ, Tnf-α and
forkhead box P3 (data not shown).
Expression of ileal Cldn1 and Tgf-ß mRNA in diabetic
and non-diabetic DP-BB rats The diabetic rats were killed
at diabetes onset at the age of 70 to 100 days. The non-
diabetic rats were killed at 140 days of age. Of the rats fed a
HC diet, ten diabetic and five non-diabetic rats were
analysed. Of the rats on a standard diet, ten diabetic rats
and one non-diabetic rat were analysed. Only the expres-
sion of Cldn1 and Tgf-ß was analysed, because the difference
in expression of these variables was the most pronounced
around 60 days of age.
In both the control rat groups and the HC diet-fed DP-BB
rats, the diabetic and non-diabetic rats displayed lower
expressionofCldn1 and Tgf-ß than rats younger than 50 days
of age. No differences were observed between diabetic and
non-diabetic rats (ESM Fig. 1).
Reduced serum zonulin levels in DP-BB rats fed a HC
diet Serum zonulin levels were measured in serum samples,
which had been cross-sectionally obtained in previous
experiments, of prediabetic DP-BB rats fed the standard
diet or the HC diet, and killed between 50 and 70 days of
age. As shown in Fig. 5, DP-BB rats receiving the HC diet
had reduced serum zonulin levels as compared with rats on
the standard diet. Because zonulin levels strongly correlate
with intestinal permeability [12, 14, 15], this result
indicates that the HC diet improves intestinal barrier
function in DP-BB rats via downregulation of zonulin.
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Fig. 3 Ileal mRNA expression of Ocln (a), Myo9b (b), Cldn1 (c) and
Cldn2 (d) in DP-BB rats fed the standard diet (black bars), DP-BB rats
on HC diet (white bars) and DR-BB rats fed the standard diet (hatched
bars). a No difference in ileal Ocln mRNA expression between DP-
BB rats fed the standard diet and those on the HC diet. b Increased
ileal Myo9b mRNA expression in 51- to 70-day-old DP-BB rats fed
the standard diet, as compared with other groups. c Reduced ileal
Cldn1 mRNA expression in DP-BB rats fed the standard diet as
compared with DP-BB rats on the HC diet and DR-BB rats on the
standard diet. d At 51 to 70 days of age DP-BB rats had increased
ileal Cldn2 mRNA expression compared with DR-BB rats. The data
are presented as the mean±SEM. Group sizes: DP-BB rats 21–50 days
of age (n=8), 51–70 days of age (n=8); DR-BB rats 21–50 days of
age (n=5), 51–70 days of age (n=8). *p<0.05; **p<0.01;
†p<0.1.
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Fig. 4 a Increased ileal Tgf-ß mRNA expression in DP-BB rats on the
HC diet (white bars) as compared with DP-BB rats on the standard
diet (black bars). At 51 to 70 days of age DP-BB rats on the standard
diet had reduced ileal Tgf-ß mRNA expression as compared with DR-
BB rats on the standard diet (hatched bars). b Between 21 and 50 days
of age, DP-BB rats fed the HC diet had an increased ileal Il-10 mRNA
expression as compared with age-matched DP-BB rats on the standard
diet. The data are presented as the mean±SEM. Group sizes: DP-BB
rats 21–50 days of age (n=8), 51–70 days of age (n=8); DR-BB rats
21–50 days of age (n=8), 51–70 days of age (n=8). *p<0.05;
**p<0.01. ND, not determined
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Here we provide evidence that a HC diet restores the
impaired intestinal barrier function in prediabetic DP-BB
rats as reflected by increased ileal TEER, reduced serum
zonulinlevelsandareduced urinarylactulose:mannitolratio.
Interestingly, we observed an association between pre-
diabetic intestinal permeability and diabetes outcome. Rats
with a low prediabetic intestinal permeability developed
autoimmune diabetes later or were protected against the
disease.
Tight junctions in gut epithelia are pivotal for maintaining
intestinal barrier function. Myosin IXb is an adaptor protein
involved in linking the cytoskeleton with tight junctions,
whereas claudins and occludin are involved in the architec-
ture of tight junctions itself [27–29]. High levels of myosin
IXb and claudin-2, and low levels of claudin-1 and
occludin will result in the opening of tight junctions and a
subsequent increase in intestinal permeability [27–29].
Therefore, our results for tight junction proteins may explain
why, at 65 days of age, the intestinal barrier function of DP-
BB rats on the standard diet is reduced compared with that
of DR-BB rats. Interestingly, Watts et al. [14] demonstrated
that intestinal permeability of DP-BB rats increases from the
age of 50 days, which correlates with the mRNA expression
pattern of tight junction proteins shown in the current report.
Besides tight junctions, mucins are also important for
maintaining intestinal barrier function. It was shown by
Courtois et al. that a HC diet increased intestinal mucin
levels and subsequently improved intestinal barrier function
in BB rats as demonstrated by reduced uptake of FITC-
labelled dextran across the gut epithelium [7]. These results
support those presented in this paper.
Here we show that in DP-BB rats, as opposed to DR-BB
rats, the expression of Cldn1 strongly declined over time,
leading to very low levels after the age of 50 days. The
mRNA expression levels of Myo9b, Ocln and Cldn2
showed no significant changes over time, but Myo9b and
Cldn2 mRNA expression levels were increased as compared
with DR-BB rats.
In DR-BB and DP-BB rats of 34 and 41 days of age, Neu
etal.foundreducedilealclaudin-1proteinlevelsascompared
withWistar rats,butobservednodifferences betweenDP-BB
and DR-BB rats [20]. Interestingly, like Neu et al., we also
found no difference in Cldn1 mRNA expression between
DP-BB and DR-BB rats below the age of 50 days. However,
we did observe a difference between these two rat groups
above the age of 50 days, a difference caused by the decline
of Cldn1 mRNA expression in DP-BB rats.
Interestingly, in DP-BB rats, the HC diet seemed to
normalise tight junction mRNA expression levels towards
levels observed in DR-BB rats. Therefore, the observed
patterns of decreased Myo9b and Cldn2 expression and
increased Cldn1 expression in DP-BB rats on a HC diet fits
well with the hypothesis that the HC diet has a beneficial
effect on gut permeability through modification of tight
junction functionality.
A proinflammatory intestinal cytokine environment
affects tight junction functionality and subsequently
increases intestinal permeability [12, 29]. Here, the HC
diet increased the anti-inflammatory cytokines IL-10 and
TGF-ß, whereas TNF-α and IFN-γ levels were not affected
(data not shown). The HC diet therefore creates an anti-
inflammatory cytokine milieu in the small intestine, which
might lead to improved intestinal barrier function.
In rats fed the standard diet and in DP-BB rats on a HC
diet, the animals that did not develop diabetes had no
higher ileal Cldn1 and Tgf-ß expression than the diabetic
rats. This result was not expected, but might be explained
by ageing. As shown in Figs 3 and 4, and in ESM Fig. 1,
Cldn1 and Tgf-ß expression declined with age in the DP-
BB rats, but not in the DR-BB rats. The non-diabetic DP-
BB rats were on average 50 days older than the diabetic
rats. Therefore, the comparable mRNA expression levels of
Cldn1 and Tgf-ß in diabetic and non-diabetic rats might
have been due to ageing. Unfortunately, we did not kill
non-diabetic DP-BB rats between 70 and 100 days of age.
Previous research by our group and others has shown that
theHCdietaffectsautoimmunediabetespathogenesismainly
between 30 and 70 days of age [1, 3]. DP-BB rats that were
fed a cereal-based diet until 60 to 70 days and then switched
to the HC diet were not protected against autoimmune
diabetes development, suggesting a crucial window [1, 3].
Therefore, prevention of exposure to diabetogenic triggers
in this window can affect diabetes outcome. The results
presented here show that the decline of intestinal barrier
function with age in DP-BB rats is delayed, but not
completely prevented by the HC diet. However, this delay
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Fig. 5 DP-BB rats fed the HC diet have reduced serum zonulin
levels. Zonulin levels were measured by ELISA in serum of
prediabetic DP-BB rats between 50 and 70 days of age. DP-BB rats
on the standard diet, n=11; DP-BB rats on the HC diet, n=13. The
data are presented as scatter dot plot with the mean indicated by a
horizontal line. *p<0.05
2626 Diabetologia (2010) 53:2621–2628might be enough to prevent exposure to diabetogenic triggers
in the diabetes-susceptible window and subsequently prevent
or delay autoimmune diabetes onset.
Food components and intestinal bacteria can affect the
integrity of the intestinal barrier [8, 12, 22–24]. Recently,
Mojibian et al. demonstrated that ~50% of established type 1
diabetes patients have T cell responses against wheat
polypeptides [30]. These results indicate that wheat might
be a major dietary antigen capable of inducing type 1
diabetes. An important question raised by the Mojibian
study is why in ~50% of type 1 diabetes patients a wheat
polypeptide-specific response is found. Interestingly, studies
by ourgroup and others have shown that also ~50% of type1
diabetes patients have intestinal barrier defects [13, 15].
Although Mojibian et al. did not investigate whether the
wheat-specific T cell responses correlated with impaired
intestinal barrier function, it is reasonable to hypothesise that
impaired intestinal barrier function leads to an increased
passage of intestinal diabetogenic antigens (e.g. wheat
peptides, bacterial agents) that induce the autoimmune
cascade typical of type 1 diabetes [11, 12, 31]. To prove
this hypothesis, further investigation of the relationship
between intestinal barrier function and immune responses
against intestinal antigens and beta cells in type 1 diabetes
patients will be required.
In summary, the results presented here show that in DP-
BB rats the level of prediabetic gut permeability is
associated with autoimmune diabetes development later in
life and that improvement of this intestinal barrier function
might contribute to the prevention of autoimmune diabetes
by dietary intervention with the HC diet. Changes to the
local intestinal cytokine profile, direct effects on tight
junctions and reduced zonulin production might be impor-
tant mechanisms for this effect. Taken together, these results
suggest that a HC-based diet probably prevents diabetes
development in the DP-BB rat by: (1) improving intestinal
barrier function thereby contributing to no or less induction
of the autoimmune cascade responsible for autoimmune
diabetes development [1, 7, 15]; (2) skewing the auto-
reactive T cells to a less pathogenic phenotype [1, 3, 6]; and
(3) the induction of islet neogenesis [1].
Modification of intestinal permeability either directly by
tight junction modulators or indirectly via environmental
factors like bioactive peptides, prebiotics or probiotics [8]
could be a promising approach to the development of a
whole new field of therapeutic strategies to prevent or treat
autoimmune diabetes.
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